Related Experiment Videos

Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate

G Todd1, K Dunlop, J McNaboe

  • 1Antrim Hospital, UK.

PubMed

Insights

High-dose fluticasone propionate in children with severe asthma may cause growth retardation and adrenal suppression. Reducing the dose can restore normal growth and cortisol response.

Area of Science:

  • Pediatric Endocrinology
  • Respiratory Medicine

Background:

  • Fluticasone propionate, an inhaled corticosteroid, was introduced as a safer alternative.
  • Established efficacy and safety at 200 µg/day, but not at higher doses commonly used.

Observation:

  • Growth retardation observed in six children with severe asthma on high-dose fluticasone propionate (dry powder).
  • Cortisol response assessed via insulin-induced hypoglycemia, short/low-dose tetracosactrin tests, and urinary cortisol/creatinine ratio.

Findings:

  • Six children with growth retardation showed adrenal suppression after high-dose fluticasone propionate treatment.
  • One child's growth and cortisol response normalized after reducing fluticasone dose to 500 µg/day.

Implications:

  • High-dose fluticasone propionate may impede growth and cause adrenal suppression in pediatric asthma patients.
  • Monitoring and dose adjustment are crucial for managing inhaled corticosteroid therapy in children.
Abstract

Related Concept Videos